Posts Tagged 'tumor necrosis factor blockers'

FDA asks TNF blocker makers to submit cancer reports

The FDA has asked manufacturers of certain class of drugs, known as tumor necrosis factor (TNF) blockers, to submit reports of cancers in children and adolescents due to an increased risk of lymphoma and other cancers. TNF blockers include Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol) and Simponi (golimumab).

Click here to read more…

FDA orders cancer warning for Remicade, other drugs

The Food and Drug Administration is requiring the manufacturers of Remicade and four other drugs to issue a “black-box” warning that they could increase the risk of cancer in children. The agency spent more than a year examining 30 cases of lymphoma or other cancers in children who were prescribed these drugs to treat rheumatoid arthritis, inflammatory bowel disease or Crohn’s disease. Some of these cases were fatal.

Click here to read more…

FDA: Arthritis drugs pose cancer risk to children

Federal regulators on Tuesday added stronger warnings to a group of best-selling drugs used to treat arthritis and other inflammatory diseases, saying they can increase the risk of cancer in children and adolescents. The agency studied several dozen reports of cancer in children taking the drugs, some of which were fatal. Half of the cases were lymphomas, a cancer that attacks the immune system.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.